More Evidence Links Roche (RHHBY)'s Avastin to Heart Failure in Breast Cancer Patients  
1/5/2011 7:02:06 AM

HealthDay News -- Just weeks after U.S. health officials moved to rescind approval of the drug Avastin to treat breast cancer, a new study provides more evidence that the anti-cancer medication ups the odds of congestive heart failure in these patients.